Ask Our Doctors and Nurses!

VIRAMUNE Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

VIRAMUNE Safety Reports

Total VIRAMUNE reports: 254.
VIRAMUNE FDA safety alerts: 2004 2005 .
Reported deaths: 42    Reported hospitalizations: 132.
Take VIRAMUNE Side Effects Survey or Share Your VIRAMUNE Story. Read More Here.

Showing 1-75 of 254 Next >

Physician from UNITED STATES reported VIRAMUNE problem on June 21, 2006. Female patient, 28 years of age, weighting 170.4 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: cd4 lymphocytes abnormal, stevens-johnson syndrome. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on July 07, 2006. Female patient, weighting 3.00 lb, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: ascites, chromosome abnormality, foetal disorder, hydrops foetalis, infection, maternal condition affecting foetus, multiple congenital abnormalities. VIRAMUNE dosage: 400 MG, IU. During the same period patient was treated with TRUVADA, ZIDOVUDINE. Patient died on 05/06/2006.

Health Professional from UNITED STATES reported VIRAMUNE problem on July 11, 2006. Male patient, weighting 5.48 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, pulmonary valve stenosis. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR, TENOFIVIR. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on July 11, 2006. Male patient, weighting 9.34 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, ventricular septal defect. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR, ZIDOVUDINE. Patient recovered.

Consumer or non-health professional from reported VIRAMUNE problem on Oct 20, 2005. Female patient, weighting 110.2 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: arthralgia, joint ankylosis, myalgia, rash. VIRAMUNE dosage: unknown. During the same period patient was treated with VIREAD, EMTRIVA. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from FRANCE on Dec 03, 1999. Male patient, weighting 185.2 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, cytolytic hepatitis, dysphagia, haematocrit decreased, haemoglobin decreased, heart rate increased, hepatitis cholestatic, hepatotoxicity. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported VIRAMUNE problem on Dec 03, 2002. Male patient, 37 years of age, weighting 183.0 lb, was diagnosed with hiv infection, convulsion and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: corneal perforation, dermatitis bullous, haemodialysis, haemodynamic instability, hepatic failure, hypotension, infection. VIRAMUNE dosage: unknown. During the same period patient was treated with BACTRIM DS, INDERAL, DILANTIN. Patient was hospitalized and became disabled. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on May 25, 2004. Male patient, 35 years of age, weighting 165.3 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, lung infection, respiratory failure, toxic epidermal necrolysis. VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, EPIVIR. Patient was hospitalized. Patient died on 05/16/2004.

Health Professional from UNITED STATES reported VIRAMUNE problem on June 28, 2006. Female patient, weighting 3.00 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: bradycardia, congenital anomaly, contusion, cyanosis neonatal, gastrointestinal disorder, hydrops foetalis, infantile apnoeic attack, kyphosis. VIRAMUNE dosage: unknown. During the same period patient was treated with TRUVADA, ZIDOVUDINE, WELLBUTRIN, SEROQUEL, COCAINE, TOBACCO, AMOXICILLIAN. Patient died on 05/06/2006.

VIRAMUNE problem was reported by a Physician from on Aug 07, 2006. Female patient, 51 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood hiv rna increased, renal failure. VIRAMUNE dosage: unknown. During the same period patient was treated with TRUVADA. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on July 11, 2006. Male patient, weighting 9.34 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, ventricular septal defect. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR, ZIDOVUDINE, FOLATE SUPPLEMENT. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on July 11, 2006. Male patient, weighting 5.48 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, maternal condition affecting foetus, pulmonary valve stenosis. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR, TENOFIVIR. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on June 28, 2006. Female patient, weighting 3.00 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, bradycardia neonatal, congenital anomaly, contusion, cyanosis neonatal. VIRAMUNE dosage: unknown. During the same period patient was treated with TRUVADA, ZIDOVUDINE, WELLBUTRIN, SEROQUEL, COCAINE, TOBACCO, AMOXICILLIAN. Patient died on 05/06/2006.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Aug 04, 2006. Female patient, weighting 3.00 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, bradycardia neonatal, breech presentation, caesarean section, congenital anomaly, contusion, cyanosis neonatal. VIRAMUNE dosage: 400MG, IU. During the same period patient was treated with TRUVADA, ZIDOVUDINE, WELLBUTRIN, SEROQUEL, COCAINE, TOBACCO, AMOXICILLIAN. Patient died on 05/06/2006.

Health Professional from UNITED STATES reported VIRAMUNE problem on July 11, 2006. Male patient, weighting 9.34 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, congenital anomaly, ventricular septal defect. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR, ZIDOVUDINE, FOLATE SUPPLEMENT. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on May 25, 2004. Male patient, weighting 165.3 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: cardiovascular disorder, conjunctivitis, tonsillitis, toxic epidermal necrolysis. VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, EPIVIR. Patient was hospitalized. Patient died on 05/16/2004.

Consumer or non-health professional from UGANDA reported VIRAMUNE problem on July 10, 2006. Female patient was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: ovarian cyst, stevens-johnson syndrome. VIRAMUNE dosage: unknown. During the same period patient was treated with DIDANOSINE, KALETRA, HALOPERIDOL, ARTANE. Patient died on 07/05/2006.

VIRAMUNE problem was reported by a Consumer or non-health professional from SOUTH AFRICA on Aug 14, 2006. Male patient, weighting 4.19 lb, was diagnosed with vertical infection transmission and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: jaundice neonatal, neutropenia. VIRAMUNE dosage: unknown. During the same period patient was treated with ZIDOVUDINE. Patient was hospitalized. Patient recovered.

Physician from reported VIRAMUNE problem on Mar 18, 2004. Male patient was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: congenital cystic lung, premature baby. VIRAMUNE dosage: unknown. During the same period patient was treated with LAMIVUDINE, NELFINAVIR, ZIDOVUDINE, LOPINAVIR, TENOFOVIR. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Aug 09, 2006. Female patient, 41 years of age, was diagnosed with asthma, bronchopulmonary aspergillosis allergic and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: impaired gastric emptying. VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, VIREAD, SERETIDE, ZITHROMAX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SOUTH AFRICA reported VIRAMUNE problem on Aug 03, 2006. Female patient, 33 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased. VIRAMUNE dosage: unknown. During the same period patient was treated with DIDANOSINE, ZIDOVUDINE. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Aug 08, 2006. Female patient, weighting 3.00 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: breech presentation, caesarean section, congenital syphilis, gastrointestinal disorder, hydrops foetalis, kyphosis. VIRAMUNE dosage: 400 MG, IU. During the same period patient was treated with TRUVADA, ZIDOVUDINE, WELLBUTRIN, SEROQUEL, COCAINE, TOBACCO, AMOXICILLIAN. Patient died on 05/06/2006.

Health Professional from UNITED STATES reported VIRAMUNE problem on July 11, 2006. Male patient, weighting 5.48 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, pulmonary valve stenosis. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR, TENOFIVIR. Patient recovered.

VIRAMUNE problem was reported by a Physician from on Aug 21, 2006. Male patient, 39 years of age, was diagnosed with hiv infection, pain, cellulitis, abscess and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hepatitis cholestatic. VIRAMUNE dosage: unknown. During the same period patient was treated with EPIVIR, VIREAD, DALACINE, IBUPROFEN, CLAMOXYL. Patient was hospitalized. Patient recovered.

Physician from reported VIRAMUNE problem on Aug 21, 2006. Male patient, 52 years of age, weighting 138.9 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. VIRAMUNE dosage: unknown. During the same period patient was treated with IMOVANE, KIVEXA. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from UNITED KINGDOM on Aug 17, 2006. Female patient was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: alpha 1 foetoprotein abnormal. VIRAMUNE dosage: 400MG/DAY. During the same period patient was treated with EPZICOM, COMBIVIR, RITONAVIR, SAQUINAVIR. Patient recovered.

Physician from reported VIRAMUNE problem on Aug 21, 2006. Female patient, child 7 years of age, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood lactic acid increased, fatigue, mitochondrial toxicity, myalgia, myocarditis, myositis. VIRAMUNE dosage: unknown. During the same period patient was treated with ABACAVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from on Mar 18, 2004. Male patient was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: congenital cystic lung. VIRAMUNE dosage: unknown. During the same period patient was treated with LAMIVUDINE, NELFINAVIR, ZIDOVUDINE, LOPINAVIR, TENOFOVIR. Patient recovered.

Physician from UNITED KINGDOM reported VIRAMUNE problem on Aug 17, 2006. Female patient was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: pregnancy, trisomy 21. VIRAMUNE dosage: 400MG/DAY. During the same period patient was treated with EPZICOM, COMBIVIR, RITONAVIR, SAQUINAVIR. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Sept 14, 2006. Male patient, 63 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, nausea. VIRAMUNE dosage: unknown. During the same period patient was treated with TRUVADA. Patient was hospitalized. Patient recovered.

Physician from reported VIRAMUNE problem on July 25, 2005. Male patient, weighting 7.41 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hydronephrosis, pyelectasia. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from BRAZIL on Sept 28, 2006. Male patient, weighting 6.83 lb, was diagnosed with vertical infection transmission, oral candidiasis, bronchospasm and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bronchiolitis, haemoglobin decreased, neutropenia, respiratory failure. VIRAMUNE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, NYSTATIN, PHENOTEROL. Patient was hospitalized. Patient died on 08/27/2006.

Health Professional from UNITED STATES reported VIRAMUNE problem on July 11, 2006. Male patient, weighting 5.48 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: alcohol use, atrial septal defect, pulmonary valve stenosis. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR, RETROVIR. Patient recovered.

VIRAMUNE problem was reported by a Physician from on Sept 27, 2006. Male patient, 34 years of age, weighting 216.1 lb, was diagnosed with hiv infection, essential hypertension and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hypertension. VIRAMUNE dosage: unknown. During the same period patient was treated with TRUVADA, ATENOLOL, TERTENSIF. Patient recovered.

Health Professional from reported VIRAMUNE problem on Sept 25, 2006. Female patient, weighting 6.72 lb, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: haemangioma of skin. VIRAMUNE dosage: 400MG DAILY TRANSPLACENTAL. During the same period patient was treated with COMBIVIR. Patient recovered.

VIRAMUNE problem was reported by a Physician from GERMANY on Sept 25, 2006. Female patient, weighting 174.2 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, chills, nausea, pyrexia, rash. VIRAMUNE dosage: unknown. During the same period patient was treated with KIVEXA. Patient was hospitalized. Patient recovered.

Physician from reported VIRAMUNE problem on Sept 28, 2006. Female patient, 35 years of age, weighting 138.9 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, dyspnoea, gamma-glutamyltransferase increased, lactic acidosis, malaise, microcytic anaemia, palpitations. VIRAMUNE dosage: unknown. During the same period patient was treated with TRUVADA. Patient died on 07/09/2006.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on July 11, 2006. Male patient, weighting 5.48 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, congenital anomaly, pulmonary valve stenosis. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR, RETROVIR. Patient recovered.

Consumer or non-health professional from reported VIRAMUNE problem on Sept 25, 2006. Female patient, 29 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: dyspnoea exertional, haemoptysis, immune reconstitution syndrome, infection, kaposi's sarcoma, lung neoplasm, lymphadenopathy, lymphoedema, skin ulcer. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized and became disabled. Patient recovered.

VIRAMUNE problem was reported by a Pharmacist from UNITED STATES on June 06, 2006. Male patient, 52 years of age, was diagnosed with hiv infection, gastrooesophageal reflux disease, antibiotic prophylaxis, blood cholesterol increased and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: malaise, viral load increased. VIRAMUNE dosage: unknown. During the same period patient was treated with EMTRIVA, KALETRA, ANDROGEL, BACTRIM DS, NIASPAN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on July 11, 2006. Male patient, weighting 9.34 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, ventricular septal defect. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR, ZIDOVUDINE, FOLATE SUPPLEMENT. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from FRANCE on Oct 09, 2006. Female patient, weighting 154.3 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: chills, conjunctivitis, face oedema, headache, hepatotoxicity, lymphadenopathy, skin toxicity. VIRAMUNE dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on Oct 16, 2006. Male patient, 48 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. VIRAMUNE dosage: unknown. During the same period patient was treated with KALETRA. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from UNITED KINGDOM on Aug 17, 2006. Female patient was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: trisomy 21. VIRAMUNE dosage: 400MG/DAY. During the same period patient was treated with EPZICOM, COMBIVIR, RITONAVIR, INVIRASE. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on July 11, 2006. Male patient, weighting 9.34 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, ventricular septal defect. VIRAMUNE dosage: unknown. During the same period patient was treated with TRIZIVIR, ZIDOVUDINE, FOLATE SUPPLEMENT. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Oct 09, 2006. Male patient, 50 years of age, weighting 163.1 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cytolytic hepatitis, gamma-glutamyltransferase increased, white blood cell count decreased. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported VIRAMUNE problem on Aug 17, 2006. Male patient was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: trisomy 21. VIRAMUNE dosage: 400MG/DAY. During the same period patient was treated with EPZICOM, COMBIVIR, RITONAVIR, INVIRASE. Patient recovered.

VIRAMUNE problem was reported by a Physician from on Apr 18, 2006. Male patient, 52 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: agitation, brain damage, cd4 lymphocytes increased, cognitive disorder, immune reconstitution syndrome, immune system disorder, incontinence, leukoencephalopathy, mental disorder. VIRAMUNE dosage: unknown. During the same period patient was treated with LAMIVUDINE, ABACAVIR, LOPINAVIR, AMPRENAVIR, MEDICINALPRODUCT NOT SPECIFIED BY SENDER. Patient died on 01/01/2006.

Physician from UNITED STATES reported VIRAMUNE problem on Dec 01, 2005. Female patient, 42 years of age, weighting 105.8 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: erythema multiforme, oesophageal candidiasis, pharyngitis. VIRAMUNE dosage: unknown. During the same period patient was treated with EPZICOM. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Oct 19, 2005. Male patient, 27 years of age, weighting 176.0 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anorexia, fatigue, hepatotoxicity, jaundice, liver function test abnormal, malaise, myalgia, nausea. VIRAMUNE dosage: 400 MG (200 MG,2 IN 1 D). During the same period patient was treated with COMBIVIR, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported VIRAMUNE problem on May 02, 2006. Female patient, 15 years of age, weighting 195.6 lb, was diagnosed with prophylaxis and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. VIRAMUNE dosage: (200 MG),PO. During the same period patient was treated with COMBIVIR, BIRTH CONTROL. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from UNITED STATES on Apr 14, 2006. Female patient, 36 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: rash, stevens-johnson syndrome. VIRAMUNE dosage: (200 MG),PO. During the same period patient was treated with TRUVADA. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported VIRAMUNE problem on May 19, 2006. Male patient, 29 years of age, weighting 130.3 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. VIRAMUNE dosage: 200 MG (200 MG),PO. During the same period patient was treated with TRUVADA. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Female patient was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity, pyrexia. VIRAMUNE dosage: (200 MG). Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported VIRAMUNE problem on Aug 26, 2005. Male patient, 61 years of age, weighting 154.0 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hepatitis. VIRAMUNE dosage: SEE TEXT (200 MG,BID),PO. During the same period patient was treated with ZIAGEN, ENANTHATE, DIPHENOXYLATE, GEMFIBROZIL, NORVIR, GABAPENTIN, BUPROPION, TRAZODONE. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from UNITED STATES on July 21, 2005. Male patient was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. VIRAMUNE dosage: unknown. During the same period patient was treated with ZIAGEN, ABACAVIR, EMTRIVA, GLUCOPHAGE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VIRAMUNE problem on July 29, 2005. Male patient, weighting 221.8 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. VIRAMUNE dosage: unknown. During the same period patient was treated with VIREAD, EPIVIR, CELEXA, MIRAPEX, ATENOLOL, ANDROGEL. Patient was hospitalized and became disabled. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from on Sept 25, 2006. Female patient, weighting 6.72 lb, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: haemangioma of skin. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient recovered.

Physician from reported VIRAMUNE problem on Sept 29, 2006. Male patient, weighting 121.3 lb, was diagnosed with hiv infection, epilepsy and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, onycholysis, oral candidiasis, pruritus, rash, staphylococcal infection, stevens-johnson syndrome. VIRAMUNE dosage: unknown. During the same period patient was treated with TRUVADA, DARUNAVIR, DEPAKENE, LAMICTAL, SUBUTEX, NORVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from UNITED STATES on June 21, 2006. Female patient, weighting 170.4 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: cd4 lymphocytes abnormal, stevens-johnson syndrome. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported VIRAMUNE problem on Apr 18, 2006. Male patient, 52 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: agitation, brain damage, cd4 lymphocytes increased, cognitive disorder, immune system disorder, incontinence, leukoencephalopathy, mental disorder, parkinsonism. VIRAMUNE dosage: unknown. During the same period patient was treated with LAMIVUDINE, ABACAVIR, LOPINAVIR, AMPRENAVIR, MEDICINALPRODUCT NOT SPECIFIED BY SENDER. Patient died on 01/01/2006.

VIRAMUNE problem was reported by a Consumer or non-health professional from on Sept 25, 2006. Female patient, 29 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: dyspnoea exertional, haemoptysis, immune reconstitution syndrome, infection, kaposi's sarcoma, lung neoplasm, lymphadenopathy, lymphoedema, mobility decreased. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized and became disabled. Patient recovered.

Physician from reported VIRAMUNE problem on Nov 10, 2006. Female patient, 43 years of age, weighting 123.5 lb, was diagnosed with retroviral infection, mania, insomnia and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: eye pruritus, hepatic enzyme increased, influenza like illness, pyrexia, rhinorrhoea. VIRAMUNE dosage: unknown. During the same period patient was treated with OLANZAPINE, ZOPICLONE. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from SOUTH AFRICA on May 24, 2006. Male patient, weighting 5.95 lb, was diagnosed with vertical infection transmission and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood sodium increased, gastroenteritis, metabolic acidosis, renal failure, sepsis neonatal, thrombocytopenia. VIRAMUNE dosage: unknown. During the same period patient was treated with ZIDOVUDINE. Patient was hospitalized. Patient died on 04/20/2006.

Physician from UNITED KINGDOM reported VIRAMUNE problem on Aug 17, 2006. Male patient was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: maternal condition affecting foetus, trisomy 21. VIRAMUNE dosage: 400MG/DAY. During the same period patient was treated with EPZICOM, COMBIVIR, RITONAVIR, INVIRASE, ABACAVIR. Patient recovered.

VIRAMUNE problem was reported by a Physician from on Sept 16, 2004. Male patient, 48 years of age, was diagnosed with taeniasis and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: arthralgia, arthritis, pruritus, pyrexia, rash. VIRAMUNE dosage: 200MG/DAY/PO FROM 15 JAN TO 29 JAN 2001 AND 400MG FROM 30 JAN TO 08 FEB 20. Patient was hospitalized. Patient recovered.

Physician from reported VIRAMUNE problem on Mar 28, 2000. Male patient, weighting 2.14 lb, was diagnosed with vertical infection transmission, hiv infection, hypertension and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: anaemia, hypertonia neonatal, ileus, neutropenia, thrombocytopenia. VIRAMUNE dosage: unknown. During the same period patient was treated with RETROVIR, COMBIVIR, LOXEN, ALDOMET, TENORMIN. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from on Dec 05, 2005. Female patient, 31 years of age, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: stillbirth. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR, MEDICINALPRODUCT NOT SPECIFIED BY SENDER. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on Oct 26, 2006. Male patient, weighting 132.3 lb, was diagnosed with hiv infection, furuncle and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blepharitis, cardio-respiratory arrest, conjunctivitis, food poisoning, rash, toxic epidermal necrolysis, urticaria. VIRAMUNE dosage: unknown. During the same period patient was treated with FUCIDINE CAP, TRUVADA. Patient was hospitalized. Patient died on 10/27/2006.

VIRAMUNE problem was reported by a Physician from FRANCE on June 11, 2001. Male patient, weighting 8.82 lb, was diagnosed with human immunodeficiency virus transmission and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: anaemia, lactic acidosis, lipase increased, neutropenia, tremor. VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, NORVIR, SAQUINAVIR, COLPOSEPTINE, CLAMOXYL, BACTRIM, SPECIAFOLDINE, RETROVIR. Patient died on 04/29/2001.

Consumer or non-health professional from UNITED STATES reported VIRAMUNE problem on Nov 22, 2006. Male patient, 50 years of age, weighting 105.8 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: palpitations, psychotic disorder, stevens-johnson syndrome. VIRAMUNE dosage: unknown. During the same period patient was treated with TENOFOVIR DF, FERROUS SULPHATE. Patient died on 11/13/2006.

VIRAMUNE problem was reported by a Physician from FRANCE on Apr 27, 2001. Male patient was diagnosed with acquired immunodeficiency syndrome, hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: convulsion, disturbance in attention, psychomotor skills impaired, speech disorder. VIRAMUNE dosage: 7 MG/KG/DAY X 2. During the same period patient was treated with VIDEX, ZERIT, RETROVIR. Patient was hospitalized. Patient recovered.

Physician from reported VIRAMUNE problem on Feb 16, 2001. Male patient, weighting 6.17 lb, was diagnosed with human immunodeficiency virus transmission, hiv infection, hypertension, diabetes mellitus and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: anaemia, lactic acidosis, neonatal disorder. VIRAMUNE dosage: unknown. During the same period patient was treated with RETROVIR, COMBIVIR, ALDOMET, CATAPRES, INSULIN. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Dec 14, 2000. Female patient, weighting 4.41 lb, was diagnosed with vertical infection transmission, hiv infection, human immunodeficiency virus transmission and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: body height below normal, bronchitis, developmental delay, eczema, foetal growth retardation, gastrointestinal disorder, haemangioma, hypertriglyceridaemia. VIRAMUNE dosage: unknown. During the same period patient was treated with ZERIT, VIDEX, SUSTIVA, VIRACEPT, COMBIVIR, RETROVIR, SALBUTAMOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported VIRAMUNE problem on Aug 22, 2000. Male patient, weighting 15.43 lb, was diagnosed with acquired immunodeficiency syndrome, vertical infection transmission and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood lactic acid increased, mitochondrial toxicity, nystagmus, pyramidal tract syndrome. VIRAMUNE dosage: unknown. During the same period patient was treated with RETROVIR, ZERIT, EPIVIR, VIDEX, VIRACEPT. Patient was hospitalized and became disabled. Patient recovered.

Showing 1-75 of 254 Next >